User menu

A randomized, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy, safety, and tolerability of prucalopride in men with chronic constipation

Bibliographic reference Yiannakou, Yan ; Piessevaux, Hubert ; Bouchoucha, Michel ; Schiefke, Ingolf ; Filip, Rafal ; et. al. A randomized, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy, safety, and tolerability of prucalopride in men with chronic constipation. In: The American journal of gastroenterology, Vol. 110, no. 5, p. 741-748 (2015)
Permanent URL
  1. JOHANSON J. F., KRALSTEIN J., Chronic constipation: a survey of the patient perspective : PATIENT PERSPECTIVE ON CONSTIPATION, 10.1111/j.1365-2036.2006.03238.x
  2. Herz Michael J, Kahan Ernesto, Zalevski Simon, Aframian Reuven, Kuznitz David, Reichman Sorena, Constipation: a different entity for patients and doctors, 10.1093/fampra/13.2.156
  3. Longstreth George F., Thompson W. Grant, Chey William D., Houghton Lesley A., Mearin Fermin, Spiller Robin C., Functional Bowel Disorders, 10.1053/j.gastro.2005.11.061
  4. Suares Nicole C, Ford Alexander C, Prevalence of, and Risk Factors for, Chronic Idiopathic Constipation in the Community: Systematic Review and Meta-analysis, 10.1038/ajg.2011.164
  5. Wald A, Aliment Pharmacol Ther, 28, 917 (2008)
  6. Belsey J, Aliment Pharmacol Ther, 31, 938 (2010)
  7. Irvine E.J., Ferrazzi S., Pare P., Thompson W.G., Rance L., Health-related quality of life in functional GI disorders: focus on constipation and resource utilization, 10.1111/j.1572-0241.2002.05843.x
  8. Müller-Lissner S., Tack J., Feng Y., Schenck F., Specht Gryp R., Levels of satisfaction with current chronic constipation treatment options in Europe - an internet survey, 10.1111/apt.12124
  9. Tack J, van Outryve M, Beyens G, Kerstens R, Vandeplassche L, Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives, 10.1136/gut.2008.162404
  10. Camilleri Michael, Kerstens René, Rykx An, Vandeplassche Lieve, A Placebo-Controlled Trial of Prucalopride for Severe Chronic Constipation, 10.1056/nejmoa0800670
  11. QUIGLEY E. M. M., VANDEPLASSCHE L., KERSTENS R., AUSMA J., Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation - a 12-week, randomized, double-blind, placebo-controlled study, 10.1111/j.1365-2036.2008.03884.x
  12. Tack Jan, Quigley Eamonn, Camilleri Michael, Vandeplassche Lieve, Kerstens René, Efficacy and safety of oral prucalopride in women with chronic constipation in whom laxatives have failed: an integrated analysis, 10.1177/2050640612474651
  13. Tack J., Stanghellini V., Dubois D., Joseph A., Vandeplassche L., Kerstens R., Effect of prucalopride on symptoms of chronic constipation, 10.1111/nmo.12217
  14. Ke M., Zou D., Yuan Y., Li Y., Lin L., Hao J., Hou X., Kim H. J., Prucalopride in the treatment of chronic constipation in patients from the Asia-Pacific region: a randomized, double-blind, placebo-controlled study : Prucalopride treatment for chronic constipation, 10.1111/j.1365-2982.2012.01983.x
  15. Shin A., Camilleri M., Kolar G., Erwin P., West C. P., Murad M. H., Systematic review with meta-analysis: highly selective 5-HT4 agonists (prucalopride, velusetrag or naronapride) in chronic constipation, 10.1111/apt.12571
  16. Lewis S. J., Heaton K. W., Stool Form Scale as a Useful Guide to Intestinal Transit Time, 10.3109/00365529709011203
  17. L. Frank, L. Kleinman, C. Farup, L., Psychometric Validation of a Constipation Symptom Assessment Questionnaire, 10.1080/003655299750025327
  18. dubois d., gilet h., viala-danten m., tack j., Psychometric performance and clinical meaningfulness of the Patient Assessment of Constipation – Quality of Life questionnaire in prucalopride (RESOLOR®) trials for chronic constipation, 10.1111/j.1365-2982.2009.01408.x
  19. Marquis Patrick, De La Loge Christine, Dubois Dominique, McDermott Anne, Chassany Olivier, Development and validation of the Patient Assessment of Constipation Quality of Life questionnaire, 10.1080/00365520510012208
  20. camilleri m., beyens g., kerstens r., robinson p., vandeplassche l., Safety assessment of prucalopride in elderly patients with constipation: a double-blind, placebo-controlled study, 10.1111/j.1365-2982.2009.01398.x
  21. Mendzelevski Boaz, Ausma Jannie, Chanter Dennis O., Robinson Patricia, Kerstens Rene, Vandeplassche Lieve, Camm John, Assessment of the cardiac safety of prucalopride in healthy volunteers: a randomized, double-blind, placebo- and positive-controlled thorough QT study : Prucalopride thorough QT study in healthy volunteers, 10.1111/j.1365-2125.2011.04088.x
  22. Chapman Hugh, Pasternack Michael, The action of the novel gastrointestinal prokinetic prucalopride on the HERG K+ channel and the common T897 polymorph, 10.1016/j.ejphar.2006.10.019